The concentration of tau in the interstitial and the cerebrospinal fluid of AD patients has been calculated to be at least 100 times lower,44–46 suggesting that increased levels of released tau locally might be required to achieve efficient spreading of the pathology. This evidence concerns the gene MAPT and Alzheimer disease.